Delivery Order SPE2DB22D2006-SPE2DB25FV8BP

Award Date 2/2/25
Potential Completion Date 2/3/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,178.99 firm fixed-price delivery order contract covers the supply of 4566832016 - Potassium Phosphate 45 mmol/15 ml, a pharmaceutical product, with a period of performance through January 6, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds an Indefinite...
This federal contract award, valued at $4,694.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4559642207 - Potassium Phosph 15 MMOL/5 ML 5ML, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of January 19, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a $9,549.24 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4562248429 - POTASSIUM PHOSP 45 MMOL/15 ML 15ML. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen, with the DLA Troop Support Medical. The IDC serves as the primary vehicle for...
This federal contract award, SPE2DX15D1022|SPE2DX25FUYTF, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $8,854.60 firm fixed-price delivery order is for the supply of 4,566,133,855 units of 10% potassium chloride in 15 ml cups, with a period of performance through October 18, 2024. Amerisourcebergen is a large pharmaceutical distributor and healthcare solutions provider that maintains a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,795.27 firm fixed-price delivery order is for the supply of POTASSIUM CL 10% (20 MEQ/15 ML) CUP UD 15 ML, a medical supply product. The award is not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $4,712.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of 4566707146 - Potassium Chloride Extended Release 20 MEQ Tablets in 500-count bottles. The contract has a firm fixed price and an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,525.52 delivery order is for the supply of Potassium Chloride Injection, a critical medical product used to treat potassium deficiency. The contract is a firm-fixed-price delivery order with a completion date of May 12, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of SODIUM PHOSPHATE 45 MMOL/15 ML 15ML medical supplies, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,420.21 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of January 25, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award is for the delivery of Potassium Chloride Extended-Release Tablets (500 count) to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $4,170.31, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,000.66, is a Firm Fixed Price Delivery Order that supports the procurement of 4566998612 - Sodium Phosphate 15 MMOL/5 ML 5ML. The contract has an ultimate completion date of January 22, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV8BP
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,543.30, is a Firm Fixed Price Delivery Order for the supply of Potassium Phosphate 45 mmol/15 ml 15 ml. The contract has no set-aside designation, indicating open competition.

Amerisourcebergen is the prime contractor and holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/4/25, 9:44 AM